Back
Speaker illustration

Doctor Stine Holmen

Oslo University Hospital Rikshospitalet, Oslo (Norway)

Member of:

European Society of Cardiology

Presentations

Baseline characteristics of the first one hundred and two patients enrolled in the trial DAPAgliflozin for Renal protection in Heart Transplant recipients (DAPARHT)

Event: Heart Failure 2024

Topic: Heart Transplantation

Session: Chronic heart failure - treatment 8

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources